Derek Leishman, Ph.D

Dr. Derek Leishman is Research Fellow and Global Head of Safety Pharmacology with Eli Lilly and Company.  Dr Leishman is a pharmacologist and electrophysiologist by training.  His long-standing field of interest is in safety pharmacology and in particular cardiovascular safety.  He studied for his degree and PhD at the University of Aberdeen.  Dr Leishman worked for Marion Merrell Dow in France before joining Pfizer in the UK.  After 12 years with Pfizer, Dr Leishman joined Lilly in 2005 as Research Fellow in Global Safety Pharmacology.